We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

iCAD

Offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid an... read more Featured Products: More products

Download Mobile App





iCAD Presents Latest AI Solution for Digital Breast Tomosynthesis

By MedImaging International staff writers
Posted on 28 Feb 2019
Print article
Image: ProFound AI offers an average of 8% in cancer detection rates, and a reduction by an average of 7% in the rate of unnecessary patient recalls (Photo courtesy of iCAD).
Image: ProFound AI offers an average of 8% in cancer detection rates, and a reduction by an average of 7% in the rate of unnecessary patient recalls (Photo courtesy of iCAD).
iCAD Inc. (Nashua, NH, USA), a provider of cancer detection and therapy solutions, presented its latest artificial intelligence (AI) software solution for digital breast tomosynthesis (DBT), ProFound AI, during the European Congress of Radiology (ECR) 2019, the second-largest radiological meeting in the world. Held by the European Society of Radiology, the conference took place February 27 through March 3, 2019, in Vienna, Austria.

ProFound AI is a deep-learning, cancer detection and workflow solution for DBT that delivers critical benefits to radiologists, their facilities and patients through an improvement by an average of 8% in cancer detection rates and a reduction by an average of 7% in the rate of unnecessary patient recalls. The technology is designed to detect malignant soft-tissue densities and calcifications and provides radiologists with the certainty of finding lesion and case scores.

At ECR 2019, iCAD previewed ProFound AI for 2D mammography, which is built on deep learning technology and is currently pending CE mark. iCAD also led two clinical presentations during the conference and hosted an event entitled, “AI After Dark.”

“With growing global demand for cancer detection and workflow solutions built on the latest advances in deep-learning, we are thrilled to demonstrate the unrivaled capabilities of our ProFound AI solution, which is clinically proven to help clinicians detect more cancers, decrease false positives and reduce recalls and reading time,” said Stacey Stevens, Executive Vice President and Chief Strategy and Commercial Officer at iCAD. “ProFound AI offers tremendous benefits to radiologists and their patients in identifying cancer earlier. We look forward to expanding the unique capabilities of our algorithm through new application areas, including breast cancer risk prediction, in the future.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Doppler System
Doppler BT-200
Gold Member
Radiation QA Tool
Accu-Gold 3
Imaging Table
Stille imagiQ2

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.